
    
      A randomized, double-blind, single-dosing, crossover study to compare the safety and
      pharmacokinetic characteristics of HD203 Liquid 25 mg with those of Enbrel PrefilledÂ®
      injection 25 mg after subcutaneous injection.
    
  